Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Nanotoxicology ; 18(2): 181-213, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38487921

RESUMO

The review systematizes data on the wide possibilities of practical application of carbon nanostructures. Much attention is paid to the use of carbon nanomaterials in medicine for the visualization of tumors during surgical interventions, in the creation of cosmetics, as well as in agriculture in the creation of fertilizers. Additionally, we demonstrate trends in research in the field of carbon nanomaterials with a view to elaborating targeted drug delivery systems. We also show the creation of nanosized medicinal substances and diagnostic systems, and the production of new biomaterials. A separate section is devoted to the difficulties in studying carbon nanomaterials. The review is intended for a wide range of readers, as well as for experts in the field of nanotechnology and nanomedicine.


Assuntos
Carbono , Nanoestruturas , Carbono/química , Nanoestruturas/química , Humanos , Animais , Nanomedicina/métodos , Sistemas de Liberação de Medicamentos , Materiais Biocompatíveis/química
2.
Nanomedicine ; 53: 102698, 2023 09.
Artigo em Inglês | MEDLINE | ID: mdl-37507062

RESUMO

The work aimed to investigate the biocompatibility and biological activity of the water-soluble fullerene adduct C60-Arg. It was found that the material is haemocompatible, is not cyto- and genotoxic, possesses pronounced antioxidant activity. Additionally, this paper outlines the direction of application of water-soluble fullerene adducts in the creation of neuroprotectors. It has been suggested that a putative mechanism of the protective action of the C60-Arg adduct is associated with its antioxidant properties, the ability to penetrate the blood-brain barrier, and release nitrogen monoxide as a result of the catabolism of L-arginine residues, which promote vascular relaxation. The action of the C60-Arg adduct was compared with the action of such an antioxidant as Edaravone, which is approved in Japan for the treatment of ischemic and haemorrhagic strokes.


Assuntos
Fulerenos , AVC Isquêmico , Nanoestruturas , Acidente Vascular Cerebral , Humanos , Antioxidantes/farmacologia , Antioxidantes/uso terapêutico , Fulerenos/farmacologia , Fulerenos/uso terapêutico , Fulerenos/química , Água , Acidente Vascular Cerebral/tratamento farmacológico , Isquemia , Arginina/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...